Tvardi Therapeutics (TVRD) Gross Margin (2022 - 2024)
Tvardi Therapeutics (TVRD) posted Gross Margin of 100.0% for Q4 2024, little changed sequentially from 100.0% in Q3 2024, and up 2024.0% YoY from 4.71% in Q1 2024.
Tvardi Therapeutics (TVRD) Gross Margin (2022 - 2024) Analysis & Trends
Tvardi Therapeutics has reported Gross Margin for 3 years, with the latest figure at 100.0% in Q4 2024.
- Quarterly Gross Margin rose 2024.0% year-over-year to 100.0% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 91.31% (up 2076.0% YoY) and the FY2024 annual result came in at 91.31%, up 2076.0% from the prior year.
- Gross Margin was little changed at 100.0% in Q4 2024 per TVRD's latest filing, from 100.0% in the prior quarter.
- Over five years, Gross Margin peaked at 100.0% in Q2 2022 and troughed at 34.68% in Q4 2022.
- A 3-year average of 76.6% and a median of 75.65% in 2022 frame the typical range for Gross Margin.
- The widest YoY moves for Gross Margin: up 4508 bps in 2023, down 2045 bps in 2023.
- Over 3 years, Gross Margin stood at 34.68% in 2022, then jumped by 130 bps to 79.76% in 2023, then grew by 25 bps to 100.0% in 2024.
- According to Business Quant data, Gross Margin over the past three periods registered 100.0%, 100.0%, and 100.0% for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 35.86% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 89.76% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 76.90% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 84.20% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 63.27% |
| 10 | Tvardi Therapeutics | 17.36 Mn | 17.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 100.00% |
| Sep 30, 2024 | 100.00% |
| Jun 30, 2024 | 100.00% |
| Mar 31, 2024 | 70.96% |
| Dec 31, 2023 | 79.76% |
| Sep 30, 2023 | 67.98% |
| Jun 30, 2023 | 79.55% |
| Mar 31, 2023 | 57.99% |
| Dec 31, 2022 | 34.68% |
| Sep 30, 2022 | 71.75% |
| Jun 30, 2022 | 100.00% |
| Mar 31, 2022 | 56.56% |